2 drug(s) with this reaction
96 total reports
Application Site Erythema has been reported as an adverse reaction across 2 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 96 adverse event reports mention application site erythema in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with application site erythema, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have application site erythema listed in their FDA adverse event reports, sorted by report count:
In addition to application site erythema, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
2 drug(s) manufactured by Chattem Inc have application site erythema listed in their FDA adverse event reports: MENTHOL, CAMPHOR, MENTHOL.
There are a combined 96 reports of application site erythema across 2 Chattem Inc drug(s) in the FDA adverse event database.